Jaguar Health (JAGX) Net Cash Flow Growth (5y) (2019 - 2026)
Jaguar Health (JAGX) Net Cash Flow Growth (5y) (2019 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
| 10 |
Jaguar Health |
1.44 Mn |
-10.19 Mn |
19.11 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
-37.99% |
| Dec 31, 2025 |
-8.54% |
| Sep 30, 2025 |
24.09% |
| Jun 30, 2025 |
-35.14% |
| Mar 31, 2025 |
-0.59% |
| Dec 31, 2024 |
-37.27% |
| Sep 30, 2024 |
-52.19% |
| Jun 30, 2024 |
45.84% |
| Mar 31, 2024 |
319.89% |
| Dec 31, 2023 |
11.67% |
| Sep 30, 2023 |
-26.13% |
| Jun 30, 2023 |
-1.10% |
| Mar 31, 2023 |
4.70% |
| Dec 31, 2022 |
-184.35% |
| Sep 30, 2022 |
21.20% |
| Jun 30, 2022 |
-46.00% |
| Mar 31, 2022 |
12.36% |
| Dec 31, 2021 |
49.31% |
| Sep 30, 2021 |
-56.79% |
| Jun 30, 2021 |
36.98% |
